Skip to main content

04 November 2019

Suspension HEK293 cell line platform

Download PDF – 1.1 MB

Characteristics and functionality of OXGENE’s suspension HEK293 cell line platform for viral vector manufacture - Vaccitech Collaboration

HEK293 cell lines have been utilised extensively in the production of AAV, Lentiviral and Adenoviral vectors for clinical applications. Suspension adapted variants, in contrast to adherent mode, represent a more attractive alternative, facilitating animal component-free, scalable, and highly flexible processes, along with increased compliance with cGMP manufacture. OXGENE has fully characterised a cGMP-banked HEK293 cell line, and has produced a range of engineered and application specific derivatives.

Download the resource to continue reading.